Cargando…
Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study
BACKGROUND: The ABO blood-type barrier in kidney and liver transplantation has been overcome by aggressive treatments such as B cell depletion using rituximab. However, the long-term effects of ABO-incompatible liver transplantation (ABO-I LTx) on immunological status have not previously been studie...
Autores principales: | Ueda, Daisuke, Yoshizawa, Atsushi, Kaneshiro, Masakatsu, Hirata, Yoshihiro, Yagi, Shintaro, Hata, Koichiro, Okajima, Hideaki, Egawa, Hiroto, Uemoto, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324916/ https://www.ncbi.nlm.nih.gov/pubmed/30656218 http://dx.doi.org/10.1097/TXD.0000000000000858 |
Ejemplares similares
-
Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
por: Tajima, Tetsuya, et al.
Publicado: (2019) -
Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
por: Yamada, Yohei, et al.
Publicado: (2018) -
Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022) -
Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
por: Ueda, Yoshihide, et al.
Publicado: (2017) -
ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities
por: Shagrani, Mohammad, et al.
Publicado: (2022)